# Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

> **NCT05397132** · — · RECRUITING · sponsor: **Duke University** · enrollment: 50 (estimated)

## Conditions studied

- Hematologic Malignancy

## Interventions

- **GENETIC:** Blood draw

## Key facts

- **NCT ID:** NCT05397132
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-27
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05397132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05397132, "Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05397132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*